UCALOLICTIDE
UNII UF1EL37E41

Substance Identification & Data

This profile provides standardized clinical and technical data for Ucalolictide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UF1EL37E41.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1620643-19-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
UF1EL37E41
CAS Registry Number
1620643-19-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
UCALOLICTIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12574
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ucalolictide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

UCALOLICTIDE

Common Names & Synonyms

EP 100 [WHO-DD]
EP-100 (CONJUGATE OF LUTEINIZING HORMONE-RELEASING HORMONE WITH A CATIONIC .ALPHA.-HELICAL PEPTIDE FOR THERAPY OF LHRH-EXPRESSING TUMORS)
MEMBRANE-DISRUPTING PEPTIDE EP-100
ONVITRELIN UCALONTIDE
UCALOLICTIDE [INN]

Technical Codes

EP100
EP-100
EP-100 (PEPTIDE)